STX2 and hemolytic-uremic syndrome: While changes in renal gene expression following Stx2 or Stx2/LPS co-challenge have already been characterized by Keepers et al. (32), we are the first to demonstrate that also three repetitive sub-lethal doses of Stx2 lead to considerable changes in transcriptional events in a murine model of HUS.